Hydrochloric Acid → HCID 178512758, compound

HRID 559513Notes

Reaction equation

HRID 559513 reaction equation
[S:1]1[CH:5]=[CH:4][N:3]=[C:2]1[NH:6][S:7]([C:10]1[CH:28]=[CH:27][C:13]([C:14]([NH:16][N:17]=[CH:18][C:19]2[CH:24]=[CH:23][C:22]([Cl:25])=[C:21]([Cl:26])[CH:20]=2)=[NH:15])=[CH:12][CH:11]=1)(=[O:9])=[O:8].[BH3-]C#N.[Na+].Cl>C1COCC1>[S:1]1[CH:5]=[CH:4][N:3]=[C:2]1[NH:6][S:7]([C:10]1[CH:11]=[CH:12][C:13]([C:14]([NH:16][NH:17][CH2:18][C:19]2[CH:24]=[CH:23][C:22]([Cl:25])=[C:21]([Cl:26])[CH:20]=2)=[NH:15])=[CH:27][CH:28]=1)(=[O:9])=[O:8]

Participants

5

Procedure

A solution of 4-(thiazol-2-ylsulfamoyl)-N-(3,4-dichloro-benzylideneamino)-benzamidine (0.387 mmol) and NaCNBH3 (large excess) was stirred in THF (5 mL) at room temperature. To the solution was added 6 N HCl drop wise until all starting material is consumed. The solution was quenched with sat NaHCO3 and extracted with ethyl acetate. The organic phase was collected and concentrated in vacuo. The crude product was purification by reverse phase chromatography to yield 4-(thiazol-2-ylsulfamoyl)-N-(3,4-dichlorobenzylamino)-benzamidine (0.09 mmol).

Workup

  1. customis consumed
  2. customThe solution was quenched with sat NaHCO3
  3. extractionextracted with ethyl acetate
  4. customThe organic phase was collected
  5. concentrationconcentrated in vacuo
  6. custompurification by reverse phase chromatography

Sources & evidence

ORD record
ord-de7ee9304fe44e169105fdee8a2916f5
Source dataset
uspto-grants-2011_11
Patent number
US08063080B2

Reaction notes

Loading…